Gastroenterology Market Research, Studies & Insights
Spherix Global Insights’ Gastroenterology therapeutic team is a leading provider of independent syndicated gastroenterology market research, insights & business intelligence.
On an annual basis, Spherix’s Gastroenterology team publishes over 26 studies in seven different indication areas including: Crohn’s Disease, ulcerative colitis, inflammatory bowel, celiac disease, clostridioides difficile, primary biliary cholangitis, eosinophilic esophagitis, non-alcoholic fatty liver disease & non-alcoholic steatohepatitis.
Unparalleled Gastroenterology Therapeutic Expertise
Our team of Gastroenterology experts delivers insights to pharmaceutical, life sciences, and biotechnology companies derived from gastroenterologists, healthcare providers & professionals, key opinion leaders, and the entire life sciences community. Insights from these experts help inform your product development and go-to-market strategies, helping you stay patient-focused at every step of the process.
Spherix Global Insights Gastroenterology – Your Trusted Advisor
Our clients are facing unprecedented challenges globally and must have the scientific, commercial, and operational capabilities necessary to thrive in an increasingly complex health care environment. As a trusted advisor, Spherix’s Gastroenterology syndicated market research studies empower our clients to innovate, thrive, and grow from development to launch.
Follow Spherix Gastroenterology on Social Media
Follow us for gastroenterology industry news, insights & analysis:
Twitter: https://twitter.com/SpherixGastro
LinkedIn: https://www.linkedin.com/company/spherix-global-insights/
For Guests & Current Clients
For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:
https://clientportal.spherixglobalinsights.com